About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04554511

Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.

Lead sponsor: Sun Yat-sen University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Hua Wang

CONTACT

+862087342462 [email protected]

Sponsors

Lead Sponsor

Sun Yat-sen University

This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients newly diagnosed with ENKTL
•Patients diagnosed between January 1, 2000 and August 31, 2020
•Patients older than 18 years

Exclusion Criteria

•Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.

Related studies

A Registry for People With T-cell Lymphoma

NCT05978141 · T-cell Lymphoma, NK-Cell Lymphoma, and more

RECRUITINGPhase 2

Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

NCT06406556 · Extranodal NK/T-cell Lymphoma

Active Not RecruitingPhase 1

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

NCT00336063 · Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, and more

Active Not RecruitingNA

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409 · Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and more

COMPLETEDPhase 2

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

NCT01384513 · Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 18, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,000

Start dateAug 2020

Last updatedJun 18, 2023

Condition

Extranodal NK/T-cell Lymphoma

Locations shown

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions